Skip to main content

Advertisement

SpringerLink
Log in

Regression of Ophthalmopathic Exophthalmos in Graves’ Disease After Total Thyroidectomy: a Prospective Study of a Surgical Series

  • Original Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

Autoimmune ophthalmopathy is one of the salient clinical features associated with Graves’ disease. Exophthalmos is one of the commonest manifestations of Graves’ associated ophthalmopathy. It is reported to regress after thyroidectomy favourably compared to radioiodine or antithyroid drug therapy. In this context, we present our experience based on a surgical series of Graves’ disease. This is a prospective study of 15 patients of Graves’ disease associated with ophthalmopathic exophthalmos. Preoperative and monthly postoperative evaluation of exophthalmos was done with Hertel’s exophthalmometer, apart from documenting lid, extra-ocular muscle and orbital involvement. The minimum follow-up of the cohort was 12 months. The female to male ratio was 12:3 and the mean age of the subjects was 33.4 years (18–55). Exophthalmos was bilateral in 13 and unilateral in 2 patients. All the 15 patients underwent total thyroidectomy without any major morbidity. Exophthalmos regressed in 12 patients at a mean follow-up of 15.6 ± 6.4 months (14–38) and was static in 3. None of the cases had worsened ophthalmopathy at the final follow-up. Mean regression of exophthalmos was 2.1 mm (1–5). The regression was statistically significant at P value = 0.035. Surgery has a positive impact on the regression of ophthalmopathic exophthalmos associated with Graves’ disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Rees Smith B, MacLachlan SM, Furmaniak J (1988) Autoantibodies to the thyrotropin receptor. Endocr Rev 9:106–121

    Article  CAS  PubMed  Google Scholar 

  2. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M et al (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7:481–493

    Article  CAS  Google Scholar 

  3. Kochupillai N (2000) Clinical endocrinology in India. Curr Sci 79:1061–1067

    Google Scholar 

  4. Forbes G, Gorman CA, Gehring DG et al (1983) Computer analysis of orbital fat and muscle volumes in Graves’ ophthalmopathy. Am J Neuroradiol 4:737–742

    CAS  PubMed  Google Scholar 

  5. Burch HB, Wartofsky L (1993) Graves’ ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev 14:747–793

    CAS  PubMed  Google Scholar 

  6. World Medical Organization (1996) Declaration of Helsinki. BMJ 313:1448–1449

    Google Scholar 

  7. Perros P, Kendall-Taylor P, Crombie AL (1995) Natural history of thyroid associated ophthalmopathy. Clin Endocrinol 42:45–50

    Article  CAS  Google Scholar 

  8. Bartley GB, Gorman CA, Garrity JA et al (1996) Long term follow-up of Graves ophthalmopathy in an incidence cohort. Ophthalmology 103:958–962

    Article  CAS  PubMed  Google Scholar 

  9. Reed RR (1997) In: Falk SA (ed) Thyroid-associated ophthalmopathy: treatment. Thyroid disease: endocrinology, surgery, nuclear medicine and radiotherapy, 2nd edn. Lippincott-Raven Publishers, Philadelphia, pp 359–377

    Google Scholar 

  10. Villadolid MC, Yokoyama N, Izumi M et al (1995) Untreated GD patients without clinical opthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance. J Clin Endocrinol Metab 80:2830–2833

    CAS  PubMed  Google Scholar 

  11. Wiersinga WM, Smit T, van der Garg R, Mouritis M, Koorneef L (1989) Clinical presentation of Graves’ ophthalmopathy. Ophthalmic Res 21:73–82

    Article  CAS  PubMed  Google Scholar 

  12. Riley FC (1972) Orbital pathology in Graves’ disease. Mayo Clin Proc 47:975–979

    Google Scholar 

  13. Rundle FF, Wilson CW (1945) Development and course of exophthalmos and ophthalmoplegia in Graves’ disease with special reference to the effect of thyroidectomy. Clin Sci 5:177–194

    CAS  PubMed  Google Scholar 

  14. Werner SC (1977) Modification of the classification of the eye changes of Graves’ disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab 44:203–244

    Article  CAS  PubMed  Google Scholar 

  15. Mouritz MP, Koorneef L, Wiersinga WM et al (1989) Clinical criteria for the assessment of disease activity in Graves’ ophthalmopathy: a novel approach. Br J Ophthalmol 73:639

    Article  Google Scholar 

  16. Gorman CA (1983) Temporal relationship between onset of Graves’ ophthalmopathy and diagnosis of thyrotoxicosis. Mayo Clin Proc 58:515–519

    CAS  PubMed  Google Scholar 

  17. Hegedus L, Brix TH, Vestergaard P (2004) Relationship between cigarette smoking and Graves’ ophthalmopathy. J Endocrinol Investig 27:265–271

    Article  Google Scholar 

  18. Wiersinga W, Prummel MF (1995) Therapeutic controversies. Retrobulbar radiation in Graves’ ophthalmopathy. J Clin Endocrinol Metab 80:345–347

    Article  CAS  PubMed  Google Scholar 

  19. Prummel MF, Mouritz MP, Berghout A et al (1989) Prednisone and cyclosporine in the treatment of severe Graves’ ophthalmopathy. N Engl J Med 321:1353–1359

    Article  CAS  PubMed  Google Scholar 

  20. Frilling A, Goretzki PE, Grussendorf M, Erbsloh M, Roher HD (1990) The influence of surgery on endocrine ophthalmopathy. World J Surg 14:442–446

    Article  CAS  PubMed  Google Scholar 

  21. Tallstedt L, Lundell G, Torring O, Wallin G et al (1992) Occurrence of ophthalmopathy after treatment for Graves’ hyperthyroidism. N Engl J Med 326:1733–1738

    Article  CAS  PubMed  Google Scholar 

  22. Marushak D, Faurschon S, Blichet-Toft M (1984) Regression of ophthalmopathy in Graves’ disease following thyroidectomy. Acta Ophthalmol (Copenh) 82:767–779

    Google Scholar 

  23. Laurberg P, Bulow Pedersen I, Pedersen KM et al (1986) Goiter size and outcome of medical treatment of Graves’ disease. Acta Endocrinol (Copenh) 111:39–43

    CAS  Google Scholar 

  24. Mourits MP, Lombardo SH, van der Sluijs FA, Fenton S (2004) Reliability of exophthalmos measurement and the exophthalmometry value distribution in a healthy Dutch population and in Graves’ patients. An exploratory study. Orbit 23:161–168

    Article  CAS  PubMed  Google Scholar 

  25. Amino N, Yuasa T, Yabu Y et al (1980) Exophthalmos in autoimmune thyroid disease. J Clin Endocrinol Metab 51:1232–1234

    Article  CAS  PubMed  Google Scholar 

  26. Migliori ME, Gladstone GJ (1984) Determination of the normal range of exophthalmometric values for black and white adults. Am J Ophthalmol 98:438–442

    Article  CAS  PubMed  Google Scholar 

  27. Vasanthakumar P, Kumar P, Rao M (2013) Anthropometric analysis of palpebral fissure dimensions and its position in South Indian ethnic adults. Oman Med J 28:26–32

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Stan MN, Durski JM, Brito JP, Bhagra S, Thapa P, Bahn RS (2013) Cohort study on radioactive iodine-induced hypothyroidism: implications for Graves’ ophthalmopathy and optimal timing for thyroid hormone assessment. Thyroid 23:620–625

    Article  CAS  PubMed  Google Scholar 

  29. De Bellis A, Conzo G, Cennamo G, Pane E, Bellastella G, Colella C et al (2012) Time course of Graves’ ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study. Endocrine 41:320–326

    Article  PubMed  Google Scholar 

  30. Sisson JC, Schipper MJ, Nelson CC, Freitas JE, Frueh BR (2008) Radioiodine therapy and Graves’ ophthalmopathy. J Nucl Med 49:923–930

    Article  PubMed  Google Scholar 

Download references

All the authors contributed to this manuscript intellectually, compiling data, drafting the manuscript and treating the subjects involved.

Author information

Authors and Affiliations

  1. Endocare Hospital, Vijayawada, 520002, India

    P. R. K. Bhargav & N. Vimala Devi

  2. SGPGIMS, Lucknow, India

    M. Sabaretnam

  3. GMC, Guntur, India

    S. Chandra Kumar

  4. SMC, Vijayawada, India

    S. Zwalitha

Authors
  1. P. R. K. Bhargav
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Sabaretnam
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Chandra Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Zwalitha
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. Vimala Devi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. R. K. Bhargav.

Ethics declarations

Informed consent was taken from all the subjects included in the work.

Conflict of Interest

The authors declare that they have no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bhargav, P.R.K., Sabaretnam, M., Kumar, S.C. et al. Regression of Ophthalmopathic Exophthalmos in Graves’ Disease After Total Thyroidectomy: a Prospective Study of a Surgical Series. Indian J Surg 79, 521–526 (2017). https://doi.org/10.1007/s12262-016-1516-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-016-1516-8

Keywords

Search

Navigation